Reduced rates of axonal and dendritic growth in embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease.
Sandhoff disease is a lysosomal storage disease in which ganglioside GM2 accumulates because of a defective beta-subunit of beta-hexosaminidase. This disease is characterized by neurological manifestations, although the pathogenic mechanisms leading from GM2 accumulation to neuropathology are largely unknown. We now examine the viability, development and rates of neurite growth of embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease, the Hexb-/- mouse. GM2 was detected by metabolic labelling at low levels in wild type (Hexb+/+) neurones, and increased by approximately three-fold in Hexb-/- neurones. Hexb-/- hippocampal neurones were as viable as their wild type counterparts and, moreover, their developmental programme was unaltered because the formation of axons and of the minor processes which eventually become dendrites was similar in Hexb-/- and Hexb+/+ neurones. In contrast, once formed, a striking difference in the rate of axonal and minor process growth was observed, with changes becoming apparent after 3 days in culture and highly significant after 5 days in culture. Analysis of various parameters of axonal growth suggested that a key reason for the decreased rate of axonal growth was because of a decrease in the formation of collateral axonal branches, the major mechanism by which hippocampal axons elongate in culture. Thus, although the developmental programme with respect to axon and minor process formation and the viability of hippocampal neurones are unaltered, a significant decrease occurs in the rate of axonal and minor process growth in Hexb-/- neurones. These results appear to be in contrast to dorsal root ganglion neurones cultured from 1-month-old Sandhoff mice, in which cell survival is impaired but normal outgrowth of neurones occurs. The possible reasons for these differences are discussed.
Pelled
D
D
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Riebeling
C
C
van Echten-Deckert
G
G
Sandhoff
K
K
Futerman
A H
AH
D000818:Animals; D001369:Axons / Q000473:pathology*; D001426:Bacterial Proteins / Q000235:genetics; D002470:Cell Survival; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000235:genetics; D003712:Dendrites / Q000473:pathology*; D004195:Disease Models, Animal; D020143:Gangliosidoses, GM2 / Q000378:metabolism; D006624:Hippocampus / Q000166:cytology* / Q000196:embryology; D051379:Mice; D008817:Mice, Mutant Strains; D009474:Neurons / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D012497:Sandhoff Disease / Q000473:pathology*
D001426:Bacterial Proteins; D004268:DNA-Binding Proteins